| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a37dda4c4b4a12212bd02bd01b0acab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa1059150ca9eda894e56ca8bcb8a5e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7193d20595c48585427a08ed364dfd11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d524326b95652ec03d212469fee123fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b8e6189a14aa1fbb7b5e0af169f33c |
| publicationDate |
2018-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DK-2864328-T3 |
| titleOfInvention |
PHARMACEUTICAL ACTIVE RELATIONS |
| abstract |
The present invention relates to compounds of formula I: wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The compounds of formula I are inhibitors of aurora kinase and/or FLT3. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which aurora kinase and/or FLT3 activity is implicated. |
| priorityDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |